These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9951841)

  • 21. Necrosis of hepatocellular carcinoma as a result of subintimal injury incurred by hepatic angiography: report of two cases.
    Takayasu K; Muramatsu Y; Shima Y; Moriyama N; Yamada T; Yoshida T; Makuuchi M; Kishi K
    Am J Gastroenterol; 1986 Oct; 81(10):979-83. PubMed ID: 3020974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Factors related to acute upper gastrointestinal bleeding after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma].
    Wu JX; Huang JF; Yu ZJ; Meng XY; Li DG; Lu HM
    Ai Zheng; 2002 Aug; 21(8):881-4. PubMed ID: 12478898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological and histological analyses of transarterial immuno-embolization therapy (TIE) in operable patients with hepatocellular carcinoma].
    Yoshida T; Kanai T; Monden M; Kita Y; Sakon M; Gotoh M; Umeshita K; Hanike Y; Monden T; Nakamura H
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2111-4. PubMed ID: 7944415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
    Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.
    Sakamoto Y; Kita Y; Takayama T; Kawauchi N; Minagawa M; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):453-6. PubMed ID: 10228840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spontaneous rupture of a hepatocellular carcinoma successfully managed by embolization of the hepatic artery].
    Abramsohn R; Witz E; Halevy A; Manor H
    Harefuah; 1993 Jan; 124(2):68-71, 120. PubMed ID: 8382182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous regression of multiple lung metastases following regression of hepatocellular carcinoma after transcatheter arterial embolization. A case report.
    Heianna J; Miyauchi T; Suzuki T; Ishida H; Hashimoto M; Watarai J
    Hepatogastroenterology; 2007; 54(77):1560-2. PubMed ID: 17708299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma : treated with hepatic arterial embolization, an analysis of prognostic features in 150 cases.
    Eurvilaichit C; Kanjanapitak A
    J Med Assoc Thai; 2000 Sep; 83(9):983-91. PubMed ID: 11075962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiographic subsegmentectomy for the treatment of patients with small hepatocellular carcinoma.
    Iwamoto S; Sanefuji H; Okuda K
    Cancer; 2003 Feb; 97(4):1051-6. PubMed ID: 12569605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is intraoperative adjuvant therapy effective for satellite lesions in patients undergoing reduction surgery for advanced hepatocellular carcinoma?
    Taniai N; Yoshida H; Mamada Y; Kawano Y; Mizuguchi Y; Akimaru K; Tajiri T
    Hepatogastroenterology; 2006; 53(68):258-61. PubMed ID: 16608035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma.
    Itsubo M; Koike K; Tsuno S; Osada M; Komuro O; Shimada N; Okuda J; Fukada H; Okuaki Y; Kawabe T; Toda G
    Hepatogastroenterology; 2002; 49(45):735-9. PubMed ID: 12063981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in hepatic lobe volume in hepatocellular carcinoma after transcatheter arterial and percutaneous transhepatic portal embolization.
    Hatsuno T; Kaneko T; Inoue S; Sugimoto H; Takeda S; Nakao A
    Hepatogastroenterology; 2004; 51(60):1820-4. PubMed ID: 15532834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term prognosis after arterio-portal embolization for hepatocellular carcinoma.
    Mamada Y; Tajiri T; Akimaru K; Yoshida H; Taniai N
    Hepatogastroenterology; 2004; 51(55):234-6. PubMed ID: 15011871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness of hepatic arterial infusion chemotherapy using lecithin-added lipiodol emulsion in hepatocellular carcinoma].
    Kobayashi S; Koizumi S; Katagiri S; Ariizumi S; Takahashi Y; Otsubo T; Takasaki K; Yamamoto M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1433-7. PubMed ID: 17876141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal embolization in various types of liver: novel variables to predict hypertrophy.
    Kaido T; Arii S; Shimada Y; Mori A; Imamura M
    Hepatogastroenterology; 2003; 50(49):140-5. PubMed ID: 12630010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.